Lung Cancer Research Foundation Honors Women Leaders in Annual Gala
Event summary
- Lung Cancer Research Foundation (LCRF) to honor Rose Ann Weinstein and Narjust Florez, MD, FASCO at 2026 Gala on September 23, 2026.
- Weinstein, a long-time board member, has been instrumental in transforming LCRF into a national leader in lung cancer research.
- Dr. Florez, a thoracic oncologist, leads equity-driven research focused on young women and underserved populations.
- LCRF has funded 450 research grants totaling nearly $53 million, the highest amount by a nonprofit dedicated to lung cancer research.
The big picture
LCRF's gala highlights a strategic shift towards gender-specific and equity-driven research in lung cancer, addressing a critical gap in the field. With lung cancer being the leading cause of cancer deaths among women in the U.S., the foundation's focus on young women and underserved populations aligns with broader industry trends towards personalized and inclusive healthcare solutions. The event underscores the growing recognition of the need for targeted research and advocacy to improve outcomes for these often-overlooked patient groups.
What we're watching
- Funding Momentum
- Whether LCRF can sustain its funding growth and impact through high-profile events like the gala.
- Research Focus
- How LCRF's emphasis on women and young patients will shape future research priorities.
- Advocacy Impact
- The pace at which initiatives like #HearHer can drive systemic changes in lung cancer diagnosis and treatment.
Our editorial coverage: